Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.